NeuroScientific Biopharmaceuticals Ltd (NSB):企業の財務・戦略的SWOT分析

◆英語タイトル:NeuroScientific Biopharmaceuticals Ltd (NSB) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15300
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

NeuroScientific Biopharmaceuticals Ltd (NSB) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

NeuroScientific Biopharmaceuticals Ltd (NeuroScientific) develops novel pharmaceutical products that target neurological disorders which have high unmet medical needs. The company’s pipeline products include EmtinB therapeutic peptide, developed for the treatment of neurodegenerative dementia, Alzheimer’s disease, and degenerative conditions of the optic nerve; 15mS.A., a diagnostic peptide for early-stage Alzheimer’s disease. It serves in the therapeutic area of stroke-related brain injury and dementia. NeuroScientific is headqutered in Nedlands, Western Australia, Australia.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
NeuroScientific Biopharmaceuticals Ltd – Key Facts
NeuroScientific Biopharmaceuticals Ltd – Key Employees
NeuroScientific Biopharmaceuticals Ltd – Key Employee Biographies
NeuroScientific Biopharmaceuticals Ltd – Major Products and Services
NeuroScientific Biopharmaceuticals Ltd – History
NeuroScientific Biopharmaceuticals Ltd – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
NeuroScientific Biopharmaceuticals Ltd – Business Description
NeuroScientific Biopharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
NeuroScientific Biopharmaceuticals Ltd – Strengths
NeuroScientific Biopharmaceuticals Ltd – Weaknesses
NeuroScientific Biopharmaceuticals Ltd – Opportunities
NeuroScientific Biopharmaceuticals Ltd – Threats
NeuroScientific Biopharmaceuticals Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
NeuroScientific Biopharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
NeuroScientific Biopharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
NeuroScientific Biopharmaceuticals Ltd, Recent Deals Summary
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
NeuroScientific Biopharmaceuticals Ltd, Key Facts
NeuroScientific Biopharmaceuticals Ltd, Key Employees
NeuroScientific Biopharmaceuticals Ltd, Key Employee Biographies
NeuroScientific Biopharmaceuticals Ltd, Major Products and Services
NeuroScientific Biopharmaceuticals Ltd, History
NeuroScientific Biopharmaceuticals Ltd, Key Competitors
NeuroScientific Biopharmaceuticals Ltd, Ratios based on current share price
NeuroScientific Biopharmaceuticals Ltd, Annual Ratios
NeuroScientific Biopharmaceuticals Ltd, Annual Ratios (Cont...1)
NeuroScientific Biopharmaceuticals Ltd, Interim Ratios
NeuroScientific Biopharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
NeuroScientific Biopharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
NeuroScientific Biopharmaceuticals Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
NeuroScientific Biopharmaceuticals Ltd, Performance Chart (2015 - 2018)
NeuroScientific Biopharmaceuticals Ltd, Ratio Charts
NeuroScientific Biopharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
NeuroScientific Biopharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[NeuroScientific Biopharmaceuticals Ltd (NSB):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PayPal Holdings Inc:企業の戦略・SWOT・財務分析
    PayPal Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary PayPal Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ALFA, S.A.B. de C.V.:企業の戦略・SWOT・財務分析
    ALFA, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary ALFA, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Norwegian Energy Company ASA (NOR):企業の財務・戦略的SWOT分析
    Summary Norwegian Energy Company ASA (Noreco) is an upstream oil and gas company which carries out exploration, production and recovery of hydrocarbon resources. The company focuses on the development of oil and gas reserves; reservoir management and drilling activities; and acquisition of Shell’s u …
  • PriceSmart, Inc.:企業の戦略・SWOT・財務情報
    PriceSmart, Inc. - Strategy, SWOT and Corporate Finance Report Summary PriceSmart, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Guided Therapeutics Inc (GTHP)-医療機器分野:企業M&A・提携分析
    Summary Guided Therapeutics Inc (GTI), formerly SpectRx Inc is a biotechnology company that offers platform technology for the early detection of disease that leads to cancer. The company provides products for the non-invasive cervical cancer detection markets. Its products include luviva advanced c …
  • Infant Bacterial Therapeutics AB (IBT B):製薬・医療:M&Aディール及び事業提携情報
    Summary Infant Bacterial Therapeutics AB (IBT), a subsidiary of BioGaia AB is a pharmaceutical company that develops drugs influencing the human infant microbiome to treat rare diseases in premature infants. Its pipeline product candidates include IBP-9414, containing the active substance Lactobacil …
  • Globeimmune Inc (GBIM):企業の財務・戦略的SWOT分析
    Summary Globeimmune Inc (Globeimmune) is a biopharmaceutical company that develops therapeutic products for treatment of cancer and infectious diseases. The company provides products for infectious disease and oncology. It offers oncology products such as GI-4000, GI-6207 and GI-6301. Globeimmune pr …
  • Laing O’Rourke Plc:企業の戦略的SWOT分析
    Laing O'Rourke Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • London and Quadrant Housing Trust:企業の戦略・SWOT・財務情報
    London and Quadrant Housing Trust - Strategy, SWOT and Corporate Finance Report Summary London and Quadrant Housing Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Cerevance Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cerevance Inc (Cerevance) is a pharmaceutical company that strives to develop medicines for the treatment of neurological and psychiatric diseases. It is also developing preclinical and clinical programs for Parkinson's disease, L-Dopa induced dyskinesia, cognitive impairment, neuroinflammat …
  • Abion Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Abion Inc (Abion) is a biopharmaceutical company that conducts research activities to develop biopharmaceutical drugs and companion diagnostic systems for the treatment of incurable diseases. The company offers preclinical phase products such as ABN101, ABN301, ABN302, ABN401, and others. It …
  • Genticel SA (GTCL)-製薬・医療分野:企業M&A・提携分析
    Summary Genticel SA (Genticel), formerly BT Pharma, is a biopharmaceutical company that develops therapeutic vaccines for women infected by the human papillomavirus. The company provides pipeline products including ProCervix, a bivalent HPV therapeutic vaccine candidate and multivalent candidate vac …
  • Sienna Biopharmaceuticals Inc (SNNA):医療機器:M&Aディール及び事業提携情報
    Summary Sienna Biopharmaceuticals Inc (Sienna Biopharmaceuticals) is a clinical-stage biopharmaceutical company that develops and commercializes topical products in medical dermatology and aesthetics. Through its topical photoparticle therapy platform, the company advanced its product SNA-001, into …
  • Posco Daewoo Corporation (047050)-石油・ガス分野:企業M&A・提携分析
    Summary Posco Daewoo Corporation (Posco Daewoo), formally known as Daewoo International Corporation, is an international trading and investment company. It is involved in international trade, resource development and project organizing businesses. The company’s operational activities include export …
  • Circassia Pharmaceuticals Plc (CIR):企業の財務・戦略的SWOT分析
    Circassia Pharmaceuticals Plc (CIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Sv. Sv. Konstantin I Elena Holding Ad:企業の戦略・SWOT・財務分析
    Sv. Sv. Konstantin I Elena Holding Ad - Strategy, SWOT and Corporate Finance Report Summary Sv. Sv. Konstantin I Elena Holding Ad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • New Age (African Global Energy) Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary New Age (African Global Energy) Ltd (New Age) is an oil and gas company that explores and develops oil and gas fields, and oil wells. The company provides activities such as include exploration, production, appraisal and development of oil and gas assets in seven sub Saharan African countrie …
  • Punjab National Bank:企業の戦略・SWOT・財務分析
    Punjab National Bank - Strategy, SWOT and Corporate Finance Report Summary Punjab National Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Georgia Power Co (GPW):電力:M&Aディール及び事業提携情報
    Summary Georgia Power Co (Georgia Power), a subsidiary of the Southern Power Company, generates, transmits, distributes and sells electricity. The company produces electricity using various sources of energy such as coal, nuclear, solar, gas and hydro. It supplies electricity in Georgia and to whole …
  • Luxottica Group S.p.A.:企業の戦略・SWOT・財務情報
    Luxottica Group S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Luxottica Group S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆